Centinel Spine Holdco's IPO

Filed Oct 7, 2026 (Form S-⁠1). No terms yet. Applied to list on NYSE as CNTL.

Ticker
CNTL

Filed Oct 7 · NYSE · Form S-1

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

Once Centinel Spine Holdco lists, Breakaway scores it against every US stock

  • Its Quality Score from its second session, ranked against 3,191 stocks
  • Every insider trade, the day it is filed
  • The lock-up's end on your calendar, once the prospectus dates it
  • An alert when its score is first set, and when it turns
Get an alert the day CNTL lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its Form S-1 on SEC EDGAR, filed Oct 7, 2026.

What does Centinel Spine Holdco do?

“We are a commercial-stage medical technology company with a singular mission to transform spine surgery by advancing motion-preserving solutions for the cervical and lumbar spine.”
From its Form S-1, filed Oct 7, 2026
Centinel Spine Holdco's facts, each with its source
FactCentinel
Spine Holdco
IncorporatedDelaware, 2026From its Form S-1 of Oct 7, 2026
HeadquartersWest Chester, PennsylvaniaFrom its Form S-1 of Oct 7, 2026
Employees138 full-time, as of June 30, 2026From its Form S-1 of Oct 7, 2026
Websitecentinelspine.comFrom its Form S-1 of Oct 7, 2026

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

Centinel Spine Holdco's facts, each with its source
FactCentinel
Spine Holdco
UnderwritersMorgan Stanley, Goldman Sachs, Piper Sandler, Canaccord Genuity, and BTIGFrom the Form S-1 filed Oct 7, 2026, as its cover names them
ExchangeNew York Stock Exchange, as CNTL (applied to list)From the Form S-1 filed Oct 7, 2026

What the filing says about its money

Centinel Spine Holdco's facts, each with its source
FactCentinel
Spine Holdco
Net loss$4.3 million, year to December 31, 2025From its Form S-1 of Oct 7, 2026, its summary financial data
Cash$25.1 million, as of June 30, 2026From its Form S-1 of Oct 7, 2026: cash and cash equivalents
Raised before the IPO$133 million in private financingsFrom its Form S-1 of Oct 7, 2026

What risks does Centinel Spine Holdco name first?

  1. “We depend entirely on sales of our prodisc products for our revenue.”
  2. “We have a limited history of commercializing certain of our products and have experienced periods of significant business changes in a short time, making it difficult for you to evaluate our business and future prospects.”
  3. “We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to maintain profitability.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of Centinel Spine Holdco's IPO

Centinel Spine Holdco's IPO dates, each with its source
WhatDay
Registration filedForm S-1, SEC EDGAROct 7, 2026
Lock-upPer its Form S-1; the day comes once it lists180 days

The other IPOs expected

The other IPOs expected or in registration
CompanyPrice

Centinel Spine Holdco IPO questions

When is Centinel Spine Holdco's IPO?

Filed Oct 7, 2026 (Form S-⁠1). No terms yet. Applied to list on NYSE as CNTL.

What is Centinel Spine Holdco's IPO price?

Centinel Spine Holdco has not set a price range yet; its Form S-⁠1 of Oct 7, 2026 leaves it blank.

Who are the underwriters?

Morgan Stanley, Goldman Sachs, Piper Sandler, Canaccord Genuity, and BTIG, as the prospectus's cover names them.

When does the lock-up end?

Its prospectus sets a lock-⁠up of 180 days; the day it ends is read from its final prospectus once it lists.

Does Breakaway rate Centinel Spine Holdco?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where Centinel Spine Holdco's price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

  • Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
  • The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
  • The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
  • The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
  • Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Once Centinel Spine Holdco lists, Breakaway scores it against every US stock

  • Its Quality Score from its second session, ranked against 3,191 stocks
  • Every insider trade, the day it is filed
  • The lock-up's end on your calendar, once the prospectus dates it
  • An alert when its score is first set, and when it turns
Get an alert the day CNTL lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed.

Not advice. Figures from each company's SEC filings, linked on each line. Breakaway is not an underwriter, broker, or adviser, and does not say where a price will go.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.